image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 9 days, don't miss out!

4Imprint

December 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • FOUR
Another update, another upgrade for 4Imprint! Trading in Q3 showed order values rose 14% while the number of orders increased 18% above the same period in 2019. Both new customer acquisition and existing customer performance have been either at or above management’s expectations. As a result, management expect to beat its long-held US$1 billion revenue target this year and achieve US$1.1 billion. Together with stable gross margins and operational leverage that will translate into pretax profit towards the upper end of estimates and “no less than US$90m.”Peel Hunt has increased eps forecasts by 8% to 243.7 cents (208p), a massive 200% rise over FY’21. In addition net cash is expected to be US$79m raising the prospect of additional r ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author